Clinical and Applied Thrombosis/Hemostasis · 2004 · 13 citations · 42 references
MedicineGeneticsHematologyHemostasisMolecular DiagnosticsRisk Factor AnalysisCoagulation AbnormalitiesCoagulation DisordersCoagulation Factor DeficienciesMolecular ScreeningMutation AnalysisThrombosisActivated Protein C ResistanceFactor V MutationGene Mutation DetectionMutationThromboembolism Risk Prediction
After the discovery of activated protein C resistance (APCR) due to factor V Leiden mutation and the causal relationship of the phenomenon with clinical thromboembolism, a wide variety of functional clotting-based assays were developed for testing of APCR in relation to the specific DNA-based analysis of FV:Q(506) Leiden. The aim of this study is to assess a clotting-based APCR assay using procoagulant crotalidae snake venom with respect to the sensitivity, specificity, and predictability for the presence of the factor V Leiden mutation. APCR testing and factor V DNA analyses have been performed concurrently on 319 patient specimens. APCR values of the patients with homozygous factor V Leiden mutation (70.4+/-13.5 s) were significantly lower (p<0.001) in comparison to the subjects with the heterozygous mutation (87.6+/-13.4 s). The assay is highly sensitive (98.7%) and specific (91.9%) for the screening of factor V Leiden mutation. The sensitivity and specificity of the APCR testing reached to 100% below the cut-off value of 120 s among the patients with homozygous factor V Leiden mutation. Therefore, this method could help the desired effective optimal screening strategy for the laboratory search of hereditary thrombophilia focusing on the diagnosis of APCR due to FV:Q(506).
42
Mutation in blood coagulation factor V associated with resistance to activated protein C
Rogier M. Bertina, Bobby P. C. Koeleman, Ted Koster et al. · Nature · 1994 · 3.8K citations
Medicine, Genetics, Hematology +14
Björn Dahlbäck, Martin Carlsson, Peter J. Svensson · Proceedings of the National Academy of Sciences · 1993 · 2K citations
Association of idiopathic venous thromboembolism with single point-mutation at Arg506 of factor V
Jan Voorberg, J Roelse, Koen Mertens et al. · The Lancet · 1994 · 436 citations
Bengt Zöller, P Svensson, Xuhua He et al. · Journal of Clinical Investigation · 1994 · 425 citations · Full text